CUMBERLAND PHARMACEUTICALS INC - 10-Q Filing
Cumberland Pharmaceuticals Inc. reported a net loss of $3.29 million for the three months ended March 31, 2026, compared to a net income of $1.25 million in the same period last year. The decline was driven by higher costs and expenses totaling $12.26 million versus $10.42 million in 2025.
Tickers: $CPIX